María Rosa
Rubio González
Profesora Titular de Universidad


Eli Lilly and Company
Indianapolis, EE. UU.Publications in collaboration with researchers from Eli Lilly and Company (4)
2017
-
Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences
Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9807-9820
2005
-
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents
Bioorganic and Medicinal Chemistry Letters, Vol. 15, Núm. 1, pp. 51-55
2004
-
(2S,1′S,2′R,3′R)-2-(2′-Carboxy-3′ -hydroxymethylcyclopropyl) Glycine Is a Highly Potent Group 2 and 3 Metabotropic Glutamate Receptor Agonist with Oral Activity
Journal of Medicinal Chemistry, Vol. 47, Núm. 2, pp. 456-466
1995
-
Conformationally constrained ACPD analogues. Synthesis and resolution of 3-aminobicyclo[3,3,0]octane-1,3-dicarboxylic acids
Tetrahedron, Vol. 51, Núm. 11, pp. 3271-3278